MEC Practice Academy 11.19
Blog|Slideshows|September 25, 2024

5 tips to reduce the liability risk of prescribing GLP-1s

An action plan for physicians to protect themselves against malpractice litigation related to medications like Ozempic.

As a specialized medical malpractice broker, I am focused on protecting my physician and surgeon clients from the imminent surge of weight loss drug-related malpractice claims. In this article, we give five tips for physicians to protect themselves from claims related to glucagon-like peptide-1 (GLP-1) medications like Ozempic.

Max Schloemann is the founder of MEDPLI Professional Liability Insurance


Related to this article

Sethu Reddy: ©Sethu Reddy
Prior authorization, step therapy and shifting coverage rules keep patients from obesity drugs with proven benefits, an endocrinologist argues — and the long-term savings make the case for broader access.